Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02628548 · ClinicalTrials.gov registry record · NA
Neural Correlates of Successful Cognitive Aging
A NA study, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- NA
- Development phase
- 175
- Enrollment target
NCT02628548: Completed NA study, sponsored by Massachusetts General Hospital.
NCT02628548 is a NA study that has completed, run by Massachusetts General Hospital. The registered enrollment target is 175 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02628548, a NA study, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 175 participants
- Enrollment target
Study Summary
Normal aging is associated with gradual cognitive declines. These mild neurocognitive disturbances affect daily functioning, health status, and quality of life, and likely account for the roughly $2.9 billion lost by the elderly each year to fraud. The goal of this project is to compare two different 8-week training programs to promote successful neural and cognitive aging. Changes in neural structure and cognitive function will be assessed in a cohort of older adults, as well as the long-term stability of these changes over 24 months.
Interventions
- BEHAVIORAL Cognitive training program
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 175 participants |
| Start Date | 2016-01-18 |
| Est. Completion | 2021-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02628548
The ClinicalTrials.gov registry entry for NCT02628548 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 175 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Cognitive training program is the first listed.
NCT02628548 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02628548 about?
NCT02628548 is a clinical study titled "Neural Correlates of Successful Cognitive Aging". Normal aging is associated with gradual cognitive declines. These mild neurocognitive disturbances affect daily functioning, health status, and quality of life, and likely account for the roughly $2.9 billion lost by the elderly each year to fraud. The goal of this project is to compare two differen...
What is the current status of trial NCT02628548?
This trial is currently completed. It is a NA study. The enrollment target is 175 participants. The study started on 2016-01-18. Estimated completion is 2021-12-31.
What interventions are being tested in trial NCT02628548?
The interventions under investigation include: Cognitive training program (BEHAVIORAL).
Who is sponsoring clinical trial NCT02628548?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.